Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-02-28 Sale | 2025-03-04 4:59 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 583 | $4.75 | $2,769 | 13,109 (Direct) | View |
2025-02-28 Sale | 2025-03-04 4:58 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 163 | $4.76 | $776 | 7,190 (Direct) | View |
2025-02-04 Sale | 2025-02-06 7:15 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 372 | $4.72 | $1,756 | 13,692 (Direct) | View |
2024-11-04 Sale | 2024-11-06 4:51 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 3,668 | $0.29 | $1,064 | 168,768 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-04-15 Option Award(A) | 2025-05-02 6:19 pm | N/A N/A | Tvardi Therapeutics Inc. | TVRD | HALL WALLACE L JR Director | 246,756 | $0 | 202,044 (Indirect) | View |
2025-04-15 Option Award(A) | 2025-05-02 6:12 pm | N/A N/A | Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director | 439,194 | $0 | 263,164 (Indirect) | View |
Ownership | 2025-05-02 4:25 pm | N/A N/A | Tvardi Therapeutics Inc. | TVRD | Tweardy Samuel David 10% Owner | 0 | $0 | 946,974 (Indirect) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Larson Jeffrey Leroy SVP, Research & Development | 10,820 | $0 | 10,820 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | O'Brien Stephen Paul Principal Accounting Officer | 7,213 | $0 | 7,213 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Chen Yixin VP, Chem, Mfg and Ctrls | 7,213 | $0 | 7,213 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Conn Avi Daniel Chief Financial Officer | 43,547 | $0 | 43,547 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Kauh John Saewook M.D. Chief Medical Officer | 36,210 | $0 | 36,210 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Alibhai Imran Nizamudin Chief Executive Officer | 182,320 | $0 | 182,320 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Shiff Susan Ph.D. Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | WYZGA MICHAEL S Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Smith Cynthia Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | Shah Sujal Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-17 Option Award | 2025-04-21 5:15 pm | N/A 2035-04-16 | Tvardi Therapeutics Inc. | TVRD | HALL WALLACE L JR Director | 12,000 | $0 | 12,000 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-12-15 | Tvardi Therapeutics Inc. | TVRD | O'Brien Stephen Paul Principal Accounting Officer | 14,751 | $0 | 14,751 (Direct) | View |
2025-04-15 Other | 2025-04-17 6:50 pm | N/A N/A | Tvardi Therapeutics Inc. | TVRD | HALL WALLACE L JR Director | 246,756 | $0 | 448,800 (Indirect) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-12-15 | Tvardi Therapeutics Inc. | TVRD | Kauh John Saewook M.D. Chief Medical Officer | 74,049 | $0 | 74,049 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-12-15 | Tvardi Therapeutics Inc. | TVRD | WYZGA MICHAEL S Director | 18,441 | $0 | 18,441 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-12-15 | Tvardi Therapeutics Inc. | TVRD | Chen Yixin VP, Chem, Mfg and Ctrls | 14,752 | $0 | 14,752 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-01-29 | Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director | 6,202 | $0 | 708,560 (Direct) | View |
2025-04-15 Other | 2025-04-17 6:50 pm | N/A N/A | Tvardi Therapeutics Inc. | TVRD | Wirk Shaheen Director | 439,194 | $0 | 708,560 (Indirect) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-01-29 | Tvardi Therapeutics Inc. | TVRD | Shah Sujal Director | 18,441 | $0 | 18,441 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2031-01-29 | Tvardi Therapeutics Inc. | TVRD | Larson Jeffrey Leroy SVP, Research & Development | 22,128 | $0 | 22,128 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2032-02-03 | Tvardi Therapeutics Inc. | TVRD | Conn Avi Daniel Chief Financial Officer | 89,053 | $0 | 89,053 (Direct) | View |
2025-04-15 Option Award | 2025-04-17 6:50 pm | N/A 2029-01-15 | Tvardi Therapeutics Inc. | TVRD | Alibhai Imran Nizamudin Chief Executive Officer | 370,832 | $0 | 370,832 (Direct) | View |